Definitive Contract 75N93024C00074
Award Date
9/30/24
Potential Completion Date
9/29/29
Potential Value
$7.8M
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Duke University
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Durham, NC 27705, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
16
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Duke University was issued by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH), a civilian agency. The $13,368,236.91 definitive contract is for an "IMMUNOLOGY QUALITY ASSESSMENT PROGRAM" and does not have a set-aside designation. Duke University's Office of Research Administration Division is the prime contractor, and the contract has a period of performance ending on September...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, awarded a $19,829,599.29 definitive cost-no-fee contract to Duke University for a Nonhuman Primate Core Humoral Immunology Laboratory to support AIDS vaccine research and development. The contract has a period of performance through March 29, 2025 and does not have a set-aside designation. Duke University's Office of Research Administration Division is the prime contractor for this award, which appears to be...
This is a federal contract award to Duke University by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH). The contract, valued at $10,236,804.91, is a Definitive Contract with a Cost Plus Fixed Fee pricing type. The contract does not have a set-aside designation. The contract is described as "TAS::75 0885::TAS", which likely refers to the task or service area, though the specific details are not provided. The...
This federal contract award is for a research program to compare multiple vaccine adjuvants using various vaccine and antigen platforms. The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) awarded a $6,757,725 definitive contract to Duke University, a private research institution, to conduct comprehensive immune assessments of adjuvant strength, quality, breadth, and durability of responses. The research will employ "omics"...
This federal contract award, valued at $13,243,407.79, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Duke University's Office of Research Administration Division. The contract, titled "TAS::75 0885::TAS MODELING IMMUNITY FOR BIODEFENSE," is a Definitive Contract with a Cost No Fee pricing type. It has an ultimate completion date of September 29, 2015 and was initially awarded on September 30, 2010....
This is a $2,361,452.65 federal contract award to Duke University, a private non-profit university, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The contract is for a Phase 1 Clinical Trial Unit to develop therapeutics against infectious diseases. It is a delivery order placed under the Therapeutics Against Infectious Diseases Phase 1 indefinite delivery, indefinite quantity (IDIQ) contract. The contract has no...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Duke University for the production of a protein called A. CON-ENV-03 140CF. The contract has a firm fixed price of $149,839.00 and was awarded on May 10, 2012, with a completion date of June 8, 2012. The contract was not set aside for any specific socioeconomic designation. Duke University, through its Office of Research...
This is a federal contract award to Duke University, a private university, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The contract is part of the Vaccine and Treatment Evaluation Units (VTEU) program, which supports clinical research on vaccines and treatments for infectious diseases. The specific award is for Task B1C1 under contract HHSN272201300017I, with a ceiling value of $1,154,053.22. The award date was...
This is a $6,178,859.14 federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Duke University. The contract is for a "NONHUMAN PRIMATE CORE VIROLOGY LABORATORY FOR AIDS VACCINE RESEARCH AND DEVELOPMENT". This is a definitive, cost-no-fee contract with a period of performance through December 14, 2024. The contract was awarded on December 22, 2017 and does not have a set-aside...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Duke University, a private non-profit research institution, for a Phase 1 Clinical Trial Unit for Therapeutics Against Infectious Diseases. The $106,491.59 delivery order contract has an ultimate completion date of December 14, 2020 and does not have a set-aside designation. This award is part of a larger master Indefinite Delivery Vehicle (IDV) contract focused on...